THADDEUS BOUGHTON: Open Payments
NPI 1043553357 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 46 payments from 9 companies in 2025. Trend: 2023 $1,020 · 2024 $790 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $252 |
| Novo Nordisk Inc | 12 | $204 |
| Corcept Therapeutics | 6 | $105 |
| Tandem Diabetes Care, Inc. | 2 | $95 |
| Sequel Med Tech, LLC | 3 | $60 |
| SANOFI-AVENTIS U.S. LLC | 3 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: Ozempic, ZEPBOUND, Korlym, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, JARDIANCE, TWIIST, TZIELD.
Industry payments across AL — which companies pay providers there.
